06:00 PM EDT, 04/23/2024 (MT Newswires) -- Centessa Pharmaceuticals ( CNTA ) said Tuesday it is seeking to raise $100 million from an underwritten public offering of American Depositary Shares, each representing one ordinary share.

The proposed offering is subject to market and other conditions and all of the ADS are being offered by the company, it said.

Centessa Pharmaceuticals ( CNTA ) intends to grant the underwriters a 30-day option to purchase up to an additional $15 million of ADS.

Price: 9.55, Change: +0.15, Percent Change: +1.60